Sorafenib plus drug-eluting bead transarterial chemoembolization for early intrahepatic stage-progressed advanced hepatocellular carcinoma refractory to conventional transarterial chemoembolization.
Wenzhe FanBowen ZhuXinlin ZhengShufan YueMingjian LuHuishuang FanLiangliang QiaoFuliang LiGuosheng YuanYanqin WuXinhua ZouHongyu WangMiao XueJiaping LiPublished in: Journal of cancer research and clinical oncology (2022)
The combination of sorafenib and DEB-TACE is safe and effective for the treatment of early ISPA-HCC.
Keyphrases